Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Featured News
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
 
Time for MNCs to Stay Sober as China Unleashes Enticing Drug Regulatory Reform
Chief Editor James Shen offers his monthly review of the Chinese healthcare sector with this issue's emphasis on the country's giant step forward to lift its drug regulat... (11/10/2017)
   
Update on Antitrust Legislative Development in China (11/15/2017)
Competition Impact Review to Be Required for All New Chinese Regulations (11/15/2017)
Ongoing Healthcare Reform in China (11/14/2017)
U.S. Employs Rarely Used Tool to Probe China IP Practices (11/14/2017)
Time for MNCs to Stay Sober as China Unleashes Enticing Drug Regulatory Reform (11/10/2017)
EddingPharm Spinoff Strives to Bring Potential Oncology Blockbusters to China (11/7/2017)
China's Healthcare Crisis: Both Rich and Poor Travel Abroad (11/1/2017)
Three Trends in Pharma Globalization (10/31/2017)
Time for MNCs to Stay Sober as China Unleashes Enticing Drug Regulatory Reform (10/31/2017)
Why Asian CROs are Turning to the European Biotech Market (10/30/2017)
CFDA Seeks Comments on the Amendments of Administrative Measures for Drug Registration (10/30/2017)
Chinese Don't Watch Their Blood Pressure, Say Lancet Studies (10/26/2017)
China FDA's Pharmaceutical Regulations Ready for Public Comments (10/26/2017)
Zai Lab, WuXi Biologics Take China on a Euphoric Drug Trip (10/23/2017)
China's Biotech Promise Is Struggling to Keep Foreign Innovators (10/19/2017)
CFDA Issues Amendments of Eight Food and...  (11/22/2017)
Fresenius Kabi Terminates Oncology Busin...  (11/22/2017)
Sichuan Kelun Pharma Acquires 20% Stake ...  (11/22/2017)
PwC: Overseas Investments by Chinese Pha...  (11/22/2017)
China Embraces AI for Diagnosis of Lung ...  (11/22/2017)
RiboBio and GE Healthcare Forges Partner...  (11/22/2017)
Chengdu Kanghong Pharma to Acquire Israe...  (11/21/2017)
Premier Li Call for Increased Supply of ...  (11/21/2017) (free)
Acasti Pharma to License Its Hypertrigly...  (11/20/2017) (free)
Listed Chinese Pharma Cos Remains Major ...  (11/19/2017)
Domestically-listed Companies Maintains ...  (11/19/2017)
CFDA Solicits Comments on Draft Amendmen...  (11/17/2017)
Recent Official and Executive Moves  (11/16/2017)
Shanghai Pharma Eyes Acquisitions in the...  (11/16/2017)
CIRC Releases Draft Amendment of Health ...  (11/16/2017)
Global Contract Pharmaceutical Manufacturing Market to R...
White House Task Force Echoes Pharma Proposals
Pharma Industry Reputation Rebounds Somewhat in 2016
Fresenius Steps Up Pharma M&A with Akorn, Merck KGaA...
Global Pharmerging Market to Grow at a CAGR of 12.88% in...
McKinsey: Chinese Healthcare Market to Reach $1 Trillion by 202...
SMEI: Chinese Drug Sales Growth Expected to Fall Further in 201...
Nicholas Hall: Global OTC Growth Hits 4.6% in MAT Q2/2017 amid ...
CPA-McKinsey China Hospital Pharmaceuticals Report: An In-depth...
Sinohealth CMH: Review of Chinese Biopharmaceutical Market 2013...
Fresenius Kabi Terminates Oncology Business Division in Chin...
Sichuan Kelun Pharma Acquires 20% Stake of Competitor Shijia...
PwC: Overseas Investments by Chinese Pharma Cos Up as Domest...
China Embraces AI for Diagnosis of Lung Cancer
RiboBio and GE Healthcare Forges Partnership for Oligonucleo...
CFDA Issues Amendments of Eight Food and Drug Regulation...
CFDA Solicits Comments on Draft Amendment to the Rules f...
CFDA Solicits Public Comments on Provisions for Regulati...
CFDA Issues New Announcement to Adjust Drug Registration...
CDE Seeks Comments on First List of Essential Drugs Elig...
China Issues New Measure to Ensure Fair Competition
China Stiffens Penalty on Parties Offering Bribes with Amend...
Shanghai Fines Novo Nordisk CNY 2.6 Mln for Distributor Lice...
U.S. Court Dismisses Lawsuit Against GSK from Private Invest...
US Prosecutors Announce First-ever Indictments Against Chine...
China to Restrict Production of API Producers in 28 Citi...
Asymchem Labs Announces 2nd TGA Inspection of Its Jilin ...
French Authority Warns Chongqing API Producer over GMP V...
Another Chinese API Producer in Data Integrity Mudpool a...
U.S. FDA Warns Chinese API Producer for Absence of Writt...
Ascentage Announces U.S. FDA Acceptance of Its IND for N...
RiboQuark Enrolls First Patient in China for a Global Pi...
Chugai Completes Phase III Study of Osteoporosis Drug wi...
CFDA Accepts BMS's NDA for Optivo (Nivolumab)
SIMM Granted Clinical Trial Approval for New Alzheimer’...
Premier Li Call for Increased Supply of Domestic Leukemi...
CIRC Releases Draft Amendment of Health Insurance Regula...
Fujian-led Inter-provincial Drug Purchase Alliance Immin...
The National Cancer Center Joins Hands with WHO on the F...
Study: Liver Cancer Linked to Traditional Chinese Medici...
Recent Official and Executive Moves
Guo Guangchang to Resign Executive Posts at All Fosun Subs...
Recent Executive Moves
Recent Official and Executive Moves
Recent Executive Moves
EU Group Warns China to Make Good on Market Access Promi...
Hays Poll: Job Seekers in China Prefer Personal Networki...
UNAIDS Calls on China to Boost Drug Manufacturing in Afr...
WiCON Publishes the China Pharmaceutical Guide 2017 (12t...
Upcoming Event: Annual Biopharma Innovation Conference 2...
Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...
WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...
  WiCON Officially Publishes Chi...
  WiCON Officially Publishes Chi...
  WiCON and PharmaGuys Launch Ph...
  WiCON Officially Publishes Chi...
  WiCON Officially Publishes Its...
© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links